Paul Tudor Jones's RGEN Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 129,522 shares of Repligen Corporation (RGEN) worth $17.31 M, representing 0.03% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 47 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in RGEN, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2025, adding 76,767 shares. Largest reduction occurred in Q1 2020, reducing 38,691 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Repligen Corporation (RGEN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Repligen Corporation (RGEN) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2014 | +24,627 | New Buy | 24,627 | $12.87 |
| Q2 2014 | -24,627 | Sold Out | 24,627 | $0.00 |
| Q1 2015 | +10,096 | New Buy | 10,096 | $30.41 |
| Q2 2015 | -2,600 | Reduce 25.75% | 7,496 | $41.22 |
| Q3 2015 | +2,035 | Add 27.15% | 9,531 | $27.80 |
| Q4 2015 | +3,279 | Add 34.40% | 12,810 | $28.26 |
| Q1 2016 | -3,320 | Reduce 25.92% | 9,490 | $26.87 |
| Q2 2016 | +3,954 | Add 41.66% | 13,444 | $27.37 |
| Q3 2016 | -13,444 | Sold Out | 13,444 | $0.00 |
| Q2 2017 | +23,752 | New Buy | 23,752 | $41.43 |
| Q3 2017 | -23,752 | Sold Out | 23,752 | $0.00 |
| Q4 2018 | +21,944 | New Buy | 21,944 | $52.73 |
| Q1 2019 | +23,798 | Add 108.45% | 45,742 | $59.07 |
| Q2 2019 | -45,742 | Sold Out | 45,742 | $0.00 |
| Q1 2020 | +7,051 | New Buy | 7,051 | $96.58 |
| Q2 2020 | -7,051 | Sold Out | 7,051 | $0.00 |
| Q4 2020 | +6,822 | New Buy | 6,822 | $191.59 |
| Q1 2021 | -2,063 | Reduce 30.24% | 4,759 | $194.37 |
| Q2 2021 | -4,759 | Sold Out | 4,759 | $0.00 |
| Q4 2021 | +1,606 | New Buy | 1,606 | $264.63 |
| Q1 2022 | -1,606 | Sold Out | 1,606 | $0.00 |
| Q3 2023 | +5,123 | New Buy | 5,123 | $159.01 |
| Q4 2023 | -5,123 | Sold Out | 5,123 | $0.00 |
| Q2 2025 | +52,755 | New Buy | 52,755 | $124.38 |
| Q3 2025 | +76,767 | Add 145.52% | 129,522 | $133.67 |
Paul Tudor Jones's Repligen Corporation Investment FAQs
Paul Tudor Jones first purchased Repligen Corporation (RGEN) in Q1 2014, acquiring 24,627 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Repligen Corporation (RGEN) for 47 quarters since Q1 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to Repligen Corporation (RGEN) was in Q3 2025, adding 129,522 shares worth $17.31 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 129,522 shares of Repligen Corporation (RGEN), valued at approximately $17.31 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Repligen Corporation (RGEN) represents approximately 0.03% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in Repligen Corporation (RGEN) was 129,522 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.